SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-24-001058
Filing Date
2024-05-07
Accepted
2024-05-07 14:43:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO THE SCHEDULE 13D sc13da211882001_05072024.htm SC 13D/A 118402
2 STOCKHOLDER LETTER, DATED MAY 6, 2024. ex991to13da211882001_050724.htm EX-99.1 17912
3 GRAPHIC image_001.jpg GRAPHIC 3998
  Complete submission text file 0000921895-24-001058.txt   143533
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Subject) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48948 | Film No.: 24921255
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2301 SUGAR BUSH RD SUITE 510 RALEIGH NC 27612
Business Address 2301 SUGAR BUSH RD SUITE 510 RALEIGH NC 27612 919 719 6360
SHAH CAPITAL MANAGEMENT (Filed by) CIK: 0001383838 (see all company filings)

IRS No.: 201804775 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13D/A